Three New Members Named to NIH Advisory Committee on Research on Women's Health
Three new members have been appointed to the National Institutes
of Health (NIH) Advisory Committee on Research on Women's
Health (ACRWH), which held its semiannual meeting on March 17 in
Bethesda, Maryland. The new members are: Linda C. Giudice, M.D.,
Ph.D., who is the Robert B. Jaffe, M.D., Endowed Professor and
Chair of the Department of Obstetrics, Gynecology and Reproductive
Sciences at the University of California, San Francisco; Nancy
H. Nielsen, M.D., Ph.D., who is the Senior Associate Dean, State
University of New York at Buffalo School of Medicine and Biomedical
Sciences, and also the President-elect of the American Medical
Association (AMA); and Debra Toney, Ph.D., R.N., who is the President
of the National Black Nurses Association (NBNA) and the Administrator, Rainbow
Medical Centers, Las Vegas, Nevada.
The NIH Revitalization Act of 1993 charges the Advisory Committee
with advising the Director of the Office of Research on Women's
Health on appropriate research activities to be undertaken by the
national research institutes with respect to women's health
research and recommendations regarding the inclusion of women in
clinical trials and opportunities for women in biomedical careers.
The committee is composed of up to 18 members who are appointed
by the NIH Director.
Dr. Giudice is a biochemist, gynecologist, and reproductive endocrinologist
whose research focuses on endometrial biology and placental-uterine
interactions, as well as environmental impacts on reproductive
health. She is recognized for her extensive knowledge on
the topics of endometriosis, implantation and ovulatory disorders,
infertility, and assisted reproduction. She recently chaired the
NIH Reproductive Medicine Network and was on the Board of Directors
of the American Society for Reproductive Medicine from 2002–2007.
She currently sits on the Society for Women's Health Research Board
of Directors and the Institute of Medicine Health Sciences Policy
Board.
Long active in organized medicine, Dr. Nielsen, who has served
as Speaker of the House of Delegates of the Medical Society of
the State of New York and as Speaker of the AMA House of Delegates,
was named president-elect of the AMA in June 2007. Following
a year-long term as president-elect, Dr. Nielsen will assume the
office of AMA president in June 2008. She will be the second woman
to hold the AMA's highest elected office. Dr. Nielsen helped
formulate policy positions for the AMA House of Delegates on such
issues as depression, alcoholism among women, Alzheimer's
disease, and priorities in clinical preventive services. Dr. Nielsen
is active at the national level in a variety of quality initiatives
including the Institute of Medicine's Roundtable on Evidence
Based Medicine and the Consumer Empowerment Committee of America's
Health Information Community. A board certified internist, she
has been named a Master of the American College of Physicians.
Elected the 10th President of the NBNA in November 2007, Dr. Toney
will be installed as NBNA President on August 5, 2008. With over
28 years of experience in health care leadership roles in family
practice management, ambulatory care, outpatient diagnostics, hospitals
and home health care, she is currently responsible for the oversight
of six primary/urgent care centers and an outpatient diagnostic
center in Las Vegas, Nevada. Dr. Toney, a Robert Wood Johnson
Executive Nurse Fellow, is the president/owner of TLC Healthcare
Services, a licensed home healthcare agency specializing in private
duty nursing and supportive care services. She developed
the Men's Health Network and is a board member of the Jourdain
Kasey Foundation, which is dedicated to increasing awareness and
early detection of ovarian cancer. The recipient of numerous
awards, Dr. Toney frequently speaks on leadership, men and women's
health, and policy and practice issues at the national and local
levels.
Continuing ACRWH members include:
Vivian W. Pinn, M.D., , Chairperson,
Associate Director for Research on Women's Health, Director, Office
of Research on Women's Health (ORWH), NIH, Bethesda, MD; Joyce
Rudick, Executive Secretary, Director, Programs and
Management, ORWH, NIH, Bethesda, MD; Alan M. Krensky, M.D., Ex-Officio, Director,
Office of Portfolio Analysis and Strategic Initiatives, Office
of the Director, NIH, Bethesda, MD; Luther Clark, M.D.,
Executive Director, Atherosclerosis, External Medical and Scientific
Affairs, Cardiovascular/Metabolic Business Unit, Merck and Company,
North Wales, PA; PonJola Coney, M.D., Senior
Associate Dean for Faculty Affairs, Virginia Commonwealth University,
Richmond, VA; Andrea Dunaif, M.D., Charles F. Kettering
Professor of Medicine and Chief, Division of Endocrinology, Metabolism
and Molecular Medicine, Northwestern University, Chicago, IL; Ronald
S. Gibbs, M.D., Professor and Chairman, Department of Obstetrics
and Gynecology, University of Colorado Healthsciences Center, Denver,
CO; Constance A. Howes, J.D., President and CEO,
Women and Infants Hospital, Providence RI; Scott J. Hultgren,
Ph.D., Helen L. Stoever Professor of Molecular Microbiology,
Washington University School of Medicine, St. Louis, MO; Linda
M. Kaste, D.D.S., Ph.D., Associate Professor and Director
of Predoctoral Dental Public Health, University of Illinois at
Chicago, Chicago, IL; Nancy Norton, Founder and President,
International Foundation for Functional Gastrointestinal Disorders,
Milwaukee, WI; Mary Beth O'Connell, Pharm.D., Associate
Professor, Wayne State University, Detroit MI; Mary I. O'Connor,
M.D., Chair, Department of Orthopedic Surgery, Department
of Orthopedics, Mayo Clinic, Jacksonville, FL; Eugene P. Orringer, M.D.,
Executive Associate Dean for Faculty Affairs and Faculty Development,
School of Medicine, University of North Carolina at Chapel Hill,
Chapel Hill, NC; Sally Rosen, M.D., Special Assistant,
Office of the Provost Director, Center for Women's Health
Research, Leadership and Advocacy, Office of the Vice President
for Research, Temple University, Philadelphia, PA; Susan P.
Sloan, M.D., Program Director, Internal Medicine, Drexel University's
College of Medicine, Easton, PA; Barbara Yee, Ph.D., Professor
and Chair, Department of Family and Consumer Sciences, University
of Hawaii at Manoa, Honolulu, HI; and Carmen D. Zorrilla, M.D.,
Professor OB-GYN, University of Puerto Rico School of Medicine,
San Juan, PR.
The Office of Research on Women's Health (ORWH), Office
of the Director, National Institutes of Health (NIH) serves as
a focal point for women's health research at the NIH. For more
information about NIH's Office of Research on Women's Health, visit http://orwh.od.nih.gov/ and
for additional information on the ACRWH, go to http://orwh.od.nih.gov/about/advisory.html.
The Office of the Director, the central office at NIH, is responsible
for setting policy for NIH, which includes 27 Institutes and Centers.
This involves planning, managing, and coordinating the programs
and activities of all NIH components. The Office of the Director
also includes program offices which are responsible for stimulating
specific areas of research throughout NIH. Additional information
is available at http://www.nih.gov/icd/od/index.html.
The National Institutes of Health (NIH) — The Nation's
Medical Research Agency — includes 27 Institutes and
Centers and is a component of the U.S. Department of Health and
Human Services. It is the primary federal agency for conducting
and supporting basic, clinical and translational medical research,
and it investigates the causes, treatments, and cures for both
common and rare diseases. For more information about NIH and
its programs, visit www.nih.gov. |